Abstract
Budesonide, a glucocorticoid, was proven to be a highly effective agent in preventing the development of lung tumors in A/J mice. In a lung tumor bioassay, budesonide produced 70% inhibition of tumor multiplicity and 94% reduction of total tumor load compared to benzopyrene (B[a]P) treated mice. Gene expression array analysis was performed on mouse lung tumors from this bioassay using Affymetrix U74Av2 GeneChips to determine gene expression changes associated with budesonide treatment. We found 363 genes that were changed between lung tumors induced by treatment with B[a]P and similar tumors treated with budesonide. Among them, 243 genes were overexpressed and 120 genes were underexpressed after budesonide treatment. In addition, 108 genes differentially expressed during mouse lung tumorigenesis (50 genes overexpressed and 58 genes underexpressed) were modulated back to normal levels after budesonide treatment when compared with the controls group. These genes are involved in a broad range of different pathways including control of cell cycle, signal transduction, and apoptosis and may play a role in the observed preventive effect. Our results suggest that budesonide exerts its effects of chemoprevention through growth arrest via Mad2/3 and through apoptosis via Bim/Blk and, by inference, caspase-8/9. Using the pathway visualization tool GenMapp, G protein pathway and MAPK cascade were also regulated by budesonide. Thus, we have determined, for the first time, the expression profiles of genes modulated by budesonide during murine lung tumorigenesis. Our results indicate that the chemopreventive effects of budesonide in the mouse lung tumorigenesis assay involved increase and decrease expression of a wide variety of genes in multiple signaling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Cancer Society (2003). Cancer Facts Fig, 4–6.
Belman S and Troll W . (1972). Cancer Res., 32, 450–454.
Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC and Conklin BR . (2002). Nat. Genet., 31, 19–20.
Dorscheid DR, Wojcik KR, Sun S, Marroquin B and White SR . (2001). Am. J. Respir. Crit. Care Med., 164, 1939–1947.
Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.
Greenstein S, Ghias K, Krett NL and Rosen ST . (2002). Clin. Cancer Res., 8, 1681–1694.
Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M and Debatin KM . (2003). Cancer Res., 63, 3112–3120.
Herzog CR, Lubet RA and You M . (1997). J. Cell Biochem. Suppl., 29, 49–63.
Huang J, Asawa T, Takato T and Sakai R . (2003). J. Biol. Chem., 16, 16.
Kitazono AA, Garza DA and Kron SJ . (2003). Mol. Genet. Genomics, 24, 24.
Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D and Ramos DM . (2003). J. Biol. Chem., 12, 12.
Malkinson AM . (1992). Cancer Res., 52, 2670s–2676s.
McDoniels-Silvers AL, Stoner GD, Lubet RA and You M . (2002). Neoplasia, 4, 141–150.
Puthalakath H and Strasser A . (2002). Cell Death Differ., 9, 505–512.
Rozengurt E . (1998). J. Cell Physiol., 177, 507–517.
Schmidt S, Rainer J, Ploner C, Presul E, Riml S and Kofler R . (2004). Cell Death Differ, 11, S45–S55.
Wang Y, Zhang Z, Kastens E, Lubet RA and You M . (2003). Cancer Res., 63, 4389–4395.
Wattenberg LW and Estensen RD . (1996). Cancer Res., 56, 5132–5135.
Wattenberg LW and Estensen RD . (1997). Carcinogenesis, 18, 2015–2017.
Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE and Kelloff GJ . (2000). Carcinogenesis, 21, 179–182.
Yao R, Wang Y, Lubet RA and You M . (2002). Oncogene, 21, 5814–5821.
Yao R, Wang Y, Lubet RA and You M . (2003). Neoplasia, 5, 41–52.
Yin XY, Grove LE and Prochownik EV . (2001). Oncogene, 20, 2908–2917.
You M, Candrian U, Maronpot RR, Stoner GD and Anderson MW . (1989). Proc. Natl. Acad. Sci. USA, 86, 3070–3074.
Yu H . (2002). Curr. Opin. Cell Biol., 14, 706–714.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yao, R., Wang, Y., Lemon, W. et al. Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions. Oncogene 23, 7746–7752 (2004). https://doi.org/10.1038/sj.onc.1207985
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207985
Keywords
This article is cited by
-
The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma
BMC Pulmonary Medicine (2015)
-
Tailoring of corticosteroids in COPD management
Current Respiratory Care Reports (2014)
-
Molecularly imprinted polymers for corticosteroids: impact of polymer format on recognition behaviour
Microchimica Acta (2013)
-
The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells
Oncogene (2007)